Early clinical diagnosis of lacunar stroke and 3-month outcomes in the glycine antagonist in neuroprotection Americas trial

被引：0
|
作者：
Phillips, Stephen J.
Dai, Dingwei
Mitnitski, Arnold
Gubitz, Gord
Johnston, K. C.
Koroshetz, W. J.
Furie, K. L.
Black, S.
Heiselman, D. E.
机构：
[1] Queen Elizabeth II Hlth Sci Ctr, Halifax, NS, Canada
[2] Dalhousie Univ, Halifax, NS, Canada
[3] Halifax Infirm, Halifax, NS, Canada
[4] Univ Virginia, Charlottesville, VA 22903 USA
[5] Massachusetts Gen Hosp, Boston, MA 02114 USA
[6] Univ Toronto, Sunnybrook Hosp, Toronto, ON, Canada
[7] Akron Med Ctr, Akron, OH USA
来源：
STROKE | 2007年 / 38卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：498 / 498
页数：1
相关论文
共 50 条
  • [1] Clinical diagnosis of Lacunar stroke in the first 6 hours after symptom onset - Analysis of data from the glycine antagonist in neuroprotection (GAIN) Americas trial
    Phillips, Stephen J.
    Dai, Dingwei
    Mitnitski, Arnold
    Gubitz, Gordon J.
    Johnston, Karen C.
    Koroshetz, Walter J.
    Furie, Karen L.
    Black, Sandra
    Heiselman, Darell E.
    STROKE, 2007, 38 (10) : 2706 - 2711
  • [2] Glycine antagonist in neuroprotection for patients with acute stroke - GAIN Americas: A randomized controlled trial
    Sacco, RL
    DeRosa, JT
    Haley, EC
    Levin, B
    Ordronneau, P
    Phillips, SJ
    Rundek, T
    Snipes, RG
    Thompson, JLP
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (13): : 1719 - 1728
  • [3] Health care resource use after acute stroke in the Glycine Antagonist in Neuroprotection (GAIN) Americas trial
    Rundek, T
    Nielsen, K
    Phillips, S
    Johnston, KC
    Hux, M
    Watson, D
    STROKE, 2004, 35 (06) : 1368 - 1374
  • [4] Efficacy and safety of GV150526 in acute stroke: Results of the GAIN Americas trial (glycine antagonist in neuroprotection)
    Sacco, RL
    Phillips, SJ
    Haley, EC
    Levin, B
    NEUROLOGY, 2000, 54 (07) : A87 - A87
  • [5] Clinical Outcomes of an Initial 3-month Trial of Conservative Treatment for Femoroacetabular Impingement
    Aditya L Kekatpure
    Taesoo Ahn
    Chul-Ho Kim
    Soong Joon Lee
    Kang Sup Yoon
    Pil Whan Yoon
    Indian Journal of Orthopaedics, 2017, 51 : 681 - 686
  • [6] Clinical Outcomes of an Initial 3-month Trial of Conservative Treatment for Femoroacetabular Impingement
    Kekatpure, Aditya L.
    Ahn, Taesoo
    Kim, Chul-Ho
    Lee, Soong Joon
    Yoon, Kang Sup
    Yoon, Pil Whan
    INDIAN JOURNAL OF ORTHOPAEDICS, 2017, 51 (06) : 681 - 686
  • [7] Healthcare resource utilization in the three months after acute stroke: A report on 1604 patients from the glycine antagonist in neuroprotection (GAIN) Americas trial
    Nielsen, K
    Phillips, SJ
    Rundek, A
    STROKE, 2001, 32 (01) : 380 - 380
  • [8] Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial
    Lees, KR
    Asplund, K
    Carolei, A
    Davis, SM
    Diener, HC
    Kaste, M
    Orgogozo, JM
    Whitehead, J
    LANCET, 2000, 355 (9219): : 1949 - 1954
  • [9] The Adverse Effect of Post-Stroke Spasticity on 3-Month Functional Outcomes
    Belagaje, Samir R.
    Lindsell, Christopher
    Alwell, Kathy
    Moomaw, Charles J.
    Dunning, Kari
    Kleindorfer, Dawn
    Woo, Daniel
    Flaherty, Matthew L.
    Adeoye, Opeolu
    Khatri, Pooja
    Broderick, Joseph P.
    Kissela, Brett
    NEUROLOGY, 2010, 74 (09) : A152 - A152
  • [10] Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke
    Hong, K. -S.
    Kang, D. -W.
    Koo, J. -S.
    Yu, K. -H.
    Han, M. -K.
    Cho, Y. -J.
    Park, J. -M.
    Bae, H. -J.
    Lee, B. -C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (12) : 1324 - 1331
12345